Press release
Carcinoembryonic Antigen Market Analysis, Growth Forecast 2024-2033
Carcinoembryonic Antigen Market Analysis
As per the report, the carcinoembryonic antigen market size has grown rapidly in recent years. It will grow from $1.07 billion in 2023 to $1.22 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. The carcinoembryonic antigen market size is expected to see rapid growth in the next few years. It will grow to $2.02 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%.
Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16011&type=smp
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth
The increase in cancer incidence is expected to propel the growth of the carcinoembryonic antigen market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells. There is a growing incidence of cancer due to factors such as lifestyle choices, environmental pollution, genetic predisposition, and an aging population. Carcinoembryonic antigen (CEA) is a tumor marker used in cancer to monitor disease progression and treatment effectiveness. For instance, in February 2024, according to the World Health Organization (WHO), a US-based intergovernmental organization, approximately 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rise in cancer incidence is driving the growth of the carcinoembryonic antigen market.
Innovative Solutions For Meeting Growing Demand With Enhanced Efficiency
Major companies operating in the carcinoembryonic antigen market are increasing their focus on developing tumor marker tests to advance the testing process and enhance diagnostic offerings. Tumor marker tests are diagnostic procedures used to detect the presence of specific substances in the body that may indicate the presence of cancer. For instance, in October 2021, Boditech Med, a South Korea-based company that develops and manufactures products for in-vitro diagnostics and diagnostic reagents, launched the ichroma Tumor triple-M diagnostic kit. It is a tumor marker tests kit approved by the Ministry of Food and Drug Safety, capable of measuring three tumor markers prostate-specific antigen (PSA), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA) simultaneously. The kit aids in early diagnosis of common cancers like prostate, liver, and colon cancer. The product's ability to provide rapid results within 15 minutes using whole blood offers cost and time-saving advantages.
The carcinoembryonic antigen market covered in this report is segmented -
1) By Test Type: Molecular Tests, Serology Tests
2) By Gender: Male, Female
3) By Application: Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Cancer, Breast Cancer, Lung Cancer, Thyroid Cancer, Ovarian Cancer, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Cancer Centers, Research And Academic Institutes
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16011&type=discount
Major companies operating in the carcinoembryonic antigen market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers, Laboratory Corporation of America Holdings, Quest Diagnostics, Agilient Technologies, Inc., Beckman Coulter Inc., bioMérieux SA, Quidel Corporation, Ortho Clinical Diagnostics, Abcam plc, RayBiotech Inc., Creative Diagnostics, Lee Biosolutions Inc., Hytest Ltd., Prospec-Tany Technogene Ltd, Boster Biological Technology, Metropolis Healthcare
Contents of the report:
1. Executive Summary
2. Carcinoembryonic Antigen Market Report Structure
3. Carcinoembryonic Antigen Market Trends And Strategies
4. Carcinoembryonic Antigen Market - Macro Economic Scenario
5. Carcinoembryonic Antigen Market Size And Growth
…..
27. Carcinoembryonic Antigen Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/carcinoembryonic-antigen-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carcinoembryonic Antigen Market Analysis, Growth Forecast 2024-2033 here
News-ID: 3582912 • Views: …
More Releases from The Business research company
Accelerated Digital Transformation Fuels Expansion in the Managed Service Provid …
How Much Is the Managed Service Providers Market Expected to Expand by 2025?
The expanse of the managed service providers market has seen remarkable escalation across recent years, projected to ascend from its 2024 valuation of $337.60 billion to $406.74 billion in 2025, reflecting a compound annual growth rate of 20.5% during this period. This upward trajectory throughout the historical timeframe stems from several key factors: the escalating intricacy inherent in…
Consistent Growth Projected for Low-Carbon Cement Alternatives Market, Reaching …
How Large Is the Low-Carbon Cement Alternatives Market Expected to Be by 2025?
The market encompassing low-carbon cement substitutes has experienced swift expansion lately; projections indicate a rise from its 2024 valuation of $7.41 billion to $8.59 billion by 2025, reflecting a compound annual growth rate of 15.9%. This historical upward trajectory is attributable to several interconnected factors, including the acceleration of urbanization trends, heightened consciousness surrounding environmental mandates, escalating…
Surging Application Across End Users Powers the Expansion of the Legacy System M …
What Is the Projected Size of the Legacy System Modernization for Banks Market by 2025?
The overall valuation for the modernization of antiquated banking systems has experienced swift expansion lately, projected to escalate from eleven point thirty-five billion US dollars in the year 2024 to thirteen point twenty-nine billion US dollars by 2025, reflecting a compound annual growth rate of seventeen point one percent. This upward trajectory observed throughout the past…
Kubernetes Backup Software Market Poised for Robust Growth, Projected to Hit $2. …
How Much Will the Kubernetes Backup Software Market Size Increase by 2025?
The valuation of the market focused on Kubernetes backup software has seen rapid expansion lately, projected to escalate from its $0.62 billion standing in 2024 to reach $0.80 billion by 2025, reflecting a strong compound annual growth rate of 27.9%. This upward trajectory during the past period stems from several key factors: a wider uptake of applications packaged as…
More Releases for Carcinoembryonic
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: Cr …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market encompassing carcinoembryonic antigen has experienced swift expansion lately, projected to progress from a valuation of $1.22 billion in 2024 to $1.38 billion the following year, reflecting a robust compound annual growth rate of…
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the carcinoembryonic antigen market has experienced swift growth in the previous years. There will be an increase from $1.22 billion in 2024 to $1.38 billion in 2025, exhibiting a compound annual growth…
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth Dri …
What combination of drivers is leading to accelerated growth in the carcinoembryonic antigen market?
The surge in cancer cases is anticipated to fuel the expansion of the carcinoembryonic antigen market in the future. Cancer is an ailment identified by unregulated proliferation and dissemination of irregular cells. The prevalence of cancer is increasing owing to aspects such as lifestyle alternatives, environmental contamination, genetic susceptibility, and a growing elderly population. Carcinoembryonic antigen (CEA)…
Carcinoembryonic Antigen (CEA) Market Size, Share | Industry Report 2026
The global Carcinoembryonic Antigen (CEA) Market was valued at $5.3 Billion in 2018 and is forecast to grow at a modest 6.1 % CAGR between 2018 and 2026, culminating in 2026 global sales of $ 9.2 Billion.
Carcinoembryonic AntigenTest is a blood test which identifies the diagnose and manage certain cancer disease like rectum and large intestine. Basically, it is used to check how well treatment is working in certain…
Carcinoembryonic Antigen Industry Continues Growth |Quest Diagnostics, GenWay Bi …
The Report “Carcinoembryonic Antigen Market Size By Application, By Gender (Male, Female), By End-user, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024” Carcinoembryonic Antigen Market will reach USD 3.0 billion by 2024
UK carcinoembryonic antigen market is projected to grow at significant CAGR of 6.7% over the forecast time period. Rapidly increasing geriatric population, technological advancements, and growing healthcare expenditure in the…
Carcinoembryonic Antigen Market – Industry Analysis Report, 2016 – 2023
Carcinoembryonic antigens are glycoproteins that play a major role in cell adhesion. Carcinoembryonic antigen is present at very low concentration in healthy adults. Normal carcinoembryonic antigen level in healthy adult is in range between 2.5-5.0 µg/L. Level up may increase due to benign disease or smoking. However, its concentration in serum rise very high in some types of cancer. Hence, carcinoembryonic antigen used as a marker and assist in monitoring…
